Anlotinib Combined with Anti‐PD1 Potentiates Anti‐Tumor Immunity via Immunogenic Cell Death and Macrophage Reprogramming.

Autor: Zou, Benkun, Jiang, Haohua, Liu, Hongyu, Lu, Jun, Qiang, Huiping, Lu, Mingfang, Yu, Lian, Zhong, Hua, Chu, Tianqing, Han, Baohui
Zdroj: Advanced Therapeutics; Nov2023, Vol. 6 Issue 11, p1-16, 16p
Databáze: Complementary Index
Externí odkaz: